We investigated the effects of dietary nitrate (NO 3 -) supplementation on the concentration of 29 plasma nitrite ([NO 2 -]), oxygen uptake ( O 2 ) kinetics and exercise tolerance in normoxia (N) 30 and hypoxia (H). In a double-blind, crossover study, twelve healthy subjects completed cycle 31 exercise tests, twice in N (20.9% O 2 ) and twice in H (13.1% O 2 ). Subjects ingested either 140 32 ml·d -1 of NO 3 --rich beetroot juice (8.4 mmol NO 3 ; BR) or NO 3 --depleted beetroot juice (PL) 33 for 3-days prior to moderate-intensity and severe-intensity exercise tests in H and N. Pre-34 exercise plasma was significantly elevated in H-BR and N-BR compared to H-PL (P 35 = 0.00) and N-PL (P = 0.00). The rate of decline in plasma was greater during severe- 36 intensity exercise in H-BR (-30±22 nM·min -1 , 95% CI; -44, -16) compared to H-PL (-7±10 37 nM·min -1 , 95% CI; -13, -1; P = 0.00) and in N-BR (-26±19 nM· min -1 , 95% CI; -38, -14) 38 compared to N-PL (-1±6 nM· min -1 , 95% CI; -5, 2; P = 0.00). During moderate-intensity 39 exercise, steady-state pulmonary O 2 was lower in H-BR (1.91±0.28 L·min -1 , 95% CI; 1.77, 40 2.13) compared to H-PL (2.05±0.25 L·min -1 , 95% CI; 1.93, 2.26, P = 0.02) and O 2 kinetics 41 was faster in H-BR (τ: 24±13 s, 95% CI; 15, 32) compared to H-PL (31±11 s, 95% CI; 23, 42 38; P = 0.04). NO 3 supplementation had no significant effect on O 2 kinetics during severe-43 intensity exercise in hypoxia, or during moderate-intensity or severe-intensity exercise in 44 normoxia. Tolerance to severe-intensity exercise was improved by NO 3 in hypoxia (H-PL: 45 197±28; 95% CI; 173, 220 vs. H-BR: 214±43 s, 95% CI; 177, 249; P = 0.04) but not 46 normoxia. The metabolism of NO 2 during exercise is altered by NO 3 supplementation, 47 exercise and to a lesser extent, hypoxia. In hypoxia, NO 3 supplementation enhances O 2 48 kinetics during moderate-intensity exercise and improves severe-intensity exercise tolerance. 51 52 53 Nitric oxide (NO) is a ubiquitous, water soluble, free radical gas which plays a crucial role in 54 many biological processes. Effective NO production is important in normal physiological 55 functioning, from the regulation of blood flow, muscle contractility and mitochondrial 56 respiration, to host defence, neurotransmission and glucose and calcium homeostasis (11, 17, 57 60). NO production via the oxidation of L-arginine, in a process catalysed by nitric oxide 58 synthase (NOS), may be blunted in conditions of reduced O 2 availability (52). It is now 59 widely accepted that NO can also be generated via an alternative pathway, whereby inorganic 60 nitrate (NO 3 -) is reduced to nitrite (NO 2 -) and further to NO. This NOS-and O 2 -independent 61 NO 3 --NO 2 --NO pathway represents a complementary system for NO synthesis spanning a 62 broad range of redox states (49). In addition to being produced endogenously, the body's 63 NO 3 stores can be increased via the diet, with green leafy vegetables and beetroot being 64 particularly rich in NO 3 -. Upon ingestion, inorganic NO 3 is absorbed from the gut and passes 65 into the systemic circulation where ~25% of it is concentrated in the saliva (50). Commensal 66 bacteria in the oral cavity then reduce the NO 3 to NO 2 -(21). Some salivary NO 2 is converted 67 into NO when swallowed into the acidic environment of the stomach (7), whilst the 68 remainder is absorbed, increasing circulating plasma NO 2 concentration [NO 2 -]. This NO 2 -69 may be reduced to NO via a number of enzymatic and non-enzymatic pathways (e.g., 70 xanthine oxidoreductase and deoxyhemoglobin), which are potentiated in hypoxic 71 environments, such as may be evident in contracting skeletal muscle (55). 72 NO plays a key role in the physiological response and adaptation to hypoxia. A reduced 73 fraction of O 2 in inspired air results in reductions in arterial O 2 concentration and intracellular 74 partial pressure of O 2 (PO 2 ). The development of muscle hypoxia leads to increased 75 metabolic perturbation (46) and reduced functional capacity at altitude (2) and in several 76 disease conditions (22, 34). In order to restore sufficient O 2 supply, local blood flow is 77 increased via hypoxia-induced vasodilatation with NO being implicated as a major mediator 78 of this process (12). NO 2 may also promote hypoxic vasodilatation in an NO-independent 79 manner (16). 80 Dietary NO 3 supplementation, in the form of nitrate salts and nitrate-rich beetroot juice (BR), 81 represents a practical method of increasing circulating plasma [NO 3 -] (31, 42, 67) and [NO 2 -] 82 (4, 33, 62). NO 3 supplementation has been shown to reduce resting blood pressure (3, 33, 42) 83 and oxygen uptake ( O 2 ) during submaximal exercise (4, 39, 40, 41, 62, 67), and to improve 84 4 exercise performance in young, healthy individuals exercising in normoxic conditions (14, 85 38), but not necessarily in well trained athletes (5-6, 66). These changes may be related to 86 NO-mediated alterations in mitochondrial efficiency (39), muscle contractile function (3, 28) 87 and enhanced muscle blood flow, with preferential distribution to type II fibers (23). These 88 physiological alterations could be particularly beneficial when normal O 2 availability (~21%) 89 is reduced. Indeed, NO 3 supplementation in the form of BR has recently been shown to 90 reduce muscle metabolic perturbation during exercise in hypoxia and to restore constant-91 work-rate exercise tolerance and post-exercise indices of oxidative function to values 92 observed in normoxia (64). BR supplementation has also been shown to extend incremental 93 exercise tolerance, improve arterial and skeletal muscle oxygenation (50), and to enhance 94 cycling economy and time-trial performance (51), in hypoxia. However, while these studies 95 suggest that BR can improve physiological responses and exercise performance in hypoxia, it 96 has yet to be determined whether the effects BR are more pronounced in hypoxia relative to 97 normoxia. 98 The dose-response and pharmacodynamic relationships of BR supplementation have recently 99 been investigated in normoxia (67) and provides a guide to enable optimal timing and dosing 100 of BR intake to elicit peak circulating plasma [NO 2 -] values. However, the kinetics of plasma 101 [NO 2 -] during hypoxic exercise and subsequent recovery, and possible changes elicited by 102 BR supplementation, are presently not known. It was recently reported that during high-103 intensity, intermittent running exercise, plasma [NO 2 -] declined significantly during 104 exhaustive exercise and showed a tendency to recover back to baseline following 15 min of 105 passive rest (68). Previous research has reported increases (1, 54) but, more commonly, 106 decreases (6, 19, 26, 42, 63) in plasma [NO 2 -] during exercise. In addition to exercise, the 107 metabolism of NO and its derivatives are known to be influenced by intracellular PO 2 and the 108 fraction of inspired oxygen (FIO 2 ). In vitro, endothelial NOS (eNOS) expression and eNOS-109 derived NO production in human endothelial cells are reduced in hypoxia (25, 53). However, 110 in vivo, eNOS expression and activity can be up-or down-regulated by hypoxia, with both 111 decreased (58) and increased (44, 48) NO bioavailability being reported in hypoxia. 112 Characterizing the kinetic changes in [NO 2 -] during exercise and recovery at different FIO 2 113 may offer insight into NO metabolism during exercise in normoxia and hypoxia. This 114 understanding may have important implications for athletes exercising in hypoxic 115 environments. 116 5 Considering that the NO 3 --NO 2 --NO pathway is facilitated in hypoxic conditions (48), we 117 reasoned that BR supplementation may modulate the changes in [NO 2 -] during exercise and 118 recovery and may help to ameliorate the negative effects of hypoxia on exercise tolerance. 119 The primary aim of this study was to investigate the effects of BR supplementation on 120 physiological responses (plasma [NO 2 -] dynamics, pulmonary O 2 and muscle oxygenation) 121 and exercise tolerance, in both normoxia and hypoxia. We hypothesized that the reduction of 122 [NO 2 -] during exercise would be greater in hypoxia compared to normoxia but that [NO 2 -] 123 would be higher at the same iso-time during exercise following BR compared to PL 124 supplementation. We also hypothesized that BR supplementation would improve moderate-125 intensity exercise economy and severe-intensity exercise tolerance in both hypoxia and 126 normoxia, with greater effects being evident in hypoxia. 127 Methods 128 Subjects 129 Twelve physically active male subjects (mean ± SD; age = 22 ± 4 yr, height = 1.80 ± 0.06 m, 130 body mass = 78 ± 6 kg, O 2peak = 58.3 ± 6.3 mL·kg -1 ·min -1 ) volunteered to take part in this 131 study. The protocol and procedures used in this study were approved by the Institutional 132 Research Ethics Committee. All subjects gave written, fully informed consent prior to 133 commencement of the study, once the experimental protocol, associated risks, and potential 134 benefits of participation had been outlined. Subjects were instructed to arrive at the 135 laboratory, at least 3 h postprandial, and to avoid strenuous exercise in the 24 h preceding 136 each testing session. Subjects were asked to refrain from caffeine and alcohol intake 6 and 24 137 h before each test, respectively, and to consume the same light pre-exercise meal of their 138 choice 4-5 h before testing. In addition to this, subjects were asked to abstain from using 139 antibacterial mouthwash and chewing gum for the duration of the study since this has been 140 shown to blunt the conversion of NO 3 to NO 2 in the oral cavity (27). Subjects were also 141 instructed to maintain their normal dietary intake for the duration of the study. All exercise 142 tests were performed at the same time of day (± 1 h) for each subject. 143 Procedures 144 Subjects were required to attend the laboratory on six occasions over a 4-wk period. All 145 exercise tests were performed using an electronically braked cycle ergometer (Lode 146 Excalibur Sport, Groningen, the Netherlands). During visit 1, subjects completed a ramp 147 6 incremental test to exhaustion for the determination of the maximal O 2 uptake ( O 2peak ) and 148 the gas exchange threshold (GET). Subjects performed 3 min of baseline cycling at 20 W and 149 80 rpm, after which the power output was increased at a rate of 30 W·min -1 in a linear fashion 150 until volitional exhaustion. The height and configuration of the saddle and handlebars were 151 recorded and reproduced in subsequent tests. The breath-by-breath pulmonary gas-exchange 152 data were collected continuously during the incremental test and averaged over 10-s periods. 153 O 2peak was determined as the highest mean O 2 during any 30-s period. The GET was 154
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cycling at 75% Δ (a power output representing GET plus 75% of the difference between the 180 power outputs at GET and O 2peak ) (65) which was continued to volitional exhaustion. Each 181 exercise bout involved an abrupt transition to the target power output initiated from a 20 W 182 baseline, with the three exercise bouts separated by 6 min of passive recovery. The severe-183 intensity exercise bout was continued until task failure as a measure of exercise tolerance. 184 The time to exhaustion was recorded when the pedal rate fell by > 10 rpm below the 80 rpm 185 pedal rate. In these bouts, the subjects were verbally encouraged to continue for as long as 186 possible. Following exhaustion, a further 10-min recovery period elapsed with subjects 187 continuing to breathe either the hypoxic or normoxic inspirate. 188 The O 2 responses for the two moderate bouts were averaged before analysis to reduce 189 breath-to-breath noise and enhance confidence in the parameters derived from the modelling 190 process (36). Blood was sampled pre-exercise (prior to any exercise and breathing of 191 experimental inspirate), then during the baseline 20 W cycling preceding the first moderate 192 transition (ModBL) and at 1(Mod1), 3 (Mod3) and 5 (Mod5) min of the first moderate-193 intensity exercise bout. Further samples were drawn during the 20 W baseline preceding the 194 severe transition (SevBL) and after 1 (Sev1) and 3 (Sev3) min of severe-intensity exercise 195 and at exhaustion (Exh). Finally, samples were drawn during recovery from the severe bout at 196 1.5 (Rec1.5), 3 (Rec3) and 10 (Rec10) min. 197 198 The inspirate was generated using a Hypoxico HYP 100 filtration system (Sporting Edge UK 199 Ltd, Basingstoke, UK), with the generator supplying the inspirate via an extension conduit to 200 a 150 L Douglas Bag (Cranlea & Co., Birmingham, UK) . This acted as a reservoir and 201 mixing chamber, and had a separate outlet tube feeding into a two-way breathing valve 
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